Stock Day Media

Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19

November 30, 2020November 30, 2020 Stock Day Media 295 Views algernon, covid19, ifenprodil, Pharmaceuticals

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or

BioTech

Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19

November 23, 2020November 23, 2020 Stock Day Media 686 Views AGNPF, algernon, covid19, ifenprodil, Pharmaceuticals

VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or

BioTech

Algernon Pharmaceuticals Provides Update on its Ifenprodil Phase 2 Clinical Trials Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

November 13, 2020November 13, 2020 Stock Day Media 464 Views algernon, biopub, clinicaltrials, ifenprodil, Pharmaceuticals, webcast

VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or

BioTech

Innovation Pharmaceuticals Receives Pre-IND Response from FDA on COVID-19 Trial

November 6, 2020November 6, 2020 Stock Day Media 337 Views covid19, innovation, IPIX, Pharmaceuticals

WAKEFIELD, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today

BioTech

Titan Pharmaceuticals Announces Uplisting to NASDAQ

October 28, 2020October 28, 2020 Stock Day Media 323 Views NASDAQ, Pharmaceuticals, TTNPD

SOUTH SAN FRANCISCO, CA–(Marketwired – Oct 8, 2015) – Titan Pharmaceuticals, Inc. (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics

Cannabis

Cannabics Pharmaceuticals receives “Intention to Grant a European Patent” notice for its System and Method for High Throughput Screening of Cancer Cells patent application

October 27, 2020October 27, 2020 Stock Day Media 643 Views cancercells, cannabics, europeanpatent, intentiongrant, Pharmaceuticals

PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, Oct. 27, 2020 TEL AVIV, Israel and BETHESDA, Maryland, Oct. 27, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc.

BioTech Technology

Screening of 11,552 Compounds Identifies Innovation Pharmaceuticals’ Brilacidin as One of the Most Promising Potential Inhibitors of the Novel Coronavirus COVID-19

April 20, 2020April 20, 2020 Stock Day Media 760 Views Biotech, brilacidin, covid19, covid19news, inhibitors, innovation, pharmaceutical stocks, Pharmaceuticals

WAKEFIELD, Mass., April 20, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased

Uncategorized

Rocky Mountain High Brands Introduces Its New Line of CBD-Infused Products

February 12, 2018 Marcus Heatherly 373 Views 0 Comments Cannabis Stocks, CDB Infused Products, hemp oils, manufacturing hemp CBD products, marijuana stocks, Pharmaceuticals

DALLAS, TX (Uptick Newswire – February 12, 2018) — Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods

Uncategorized

Innovation Pharmaceuticals Aims to Develop First Drug for Approval in Prevention of Oral Mucositis in Head and Neck Cancer Patients as Phase 2 Clinical Trial of Brilacidin Completes

October 26, 2017 Marcus Heatherly 333 Views 0 Comments biopharmaceutical, biopharmaceutical stocks, immune system defense drugs, Pharmaceuticals, study of molecules

BEVERLY, Mass., (Uptick Newswire – October 26, 2017) – Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company,